The Role of Cytoreductive Surgery in Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (31 July 2024) | Viewed by 1385
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue "The Role of Cytoreductive Surgery in Cancers" explores the significance and impact of cytoreductive surgery on various types of cancer. This collection of articles delves into this surgical approach and its outcomes. It focuses on the role of cytoreduction in improving the survival rates, reducing the tumor burden, and enhancing the effectiveness of other treatment modalities, such as chemotherapy and radiation therapy. We also discuss the challenges and limitations associated with cytoreductive surgery, as well as the potential strategies employed to overcome them. Overall, this Special Issue provides valuable insights into the evolving field of cytoreductive surgery and its potential to revolutionize cancer treatment by targeting the primary tumor site and minimizing the risk of metastasis.
Dr. Andreas Bremers
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tumor metastasis
- cytoreductive surgery (CRS)
- hyperthermic intraperitoneal chemotherapy (HIPEC)
- cytoreductive surgery
- cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
